ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Recurrence"

  • 2018 American Transplant Congress

    Thirty-Six Consecutive Kidney Transplants in Recipients with Atypical Hemolytic Uremic Syndrome: A Single-Centre Experience

    E. Favi,1 G. Ardissino,2 D. Cresseri,3 J. Brocca,1 S. Testa,4 F. Tel,4 A. Giussani,1 C. Colico,1 C. Beretta,1 M. Ferraresso.1

    1Kidney Transplantation, Fondazione IRCCS Ca' Granda, Milan, Italy; 2Centre for HUS Prevention, Control and Management, Fondazione IRCCS Ca' Granda, Milan, Italy; 3Nephrology, Fondazione IRCCS Ca' Granda, Milan, Italy; 4Pediatric Nephrology, Fondazione IRCCS Ca' Granda, Milan, Italy.

    Background. Due to high recurrence rate, poor kidney transplant (KTx) survival has been reported for recipients with atypical hemolytic uremic syndrome (aHUS). More recently, prophylaxis…
  • 2018 American Transplant Congress

    Impact of Antecedent Malignancy on Kidney Transplant Outcomes: Patient, Graft, and Cancer-Free Survival

    O. Serrano,1 S. Mongin,2 D. Berglund,1 D. Vock,3 S. Chinnakotla,1 T. Dunn,1 E. Finger,1 R. Kandaswamy,1 T. Pruett,1 A. Matas.1

    1Surgery, University of Minnesota, Minneapolis, MN; 2Biostatistical Design and Analysis Center, Clinical and Translational Science Institute, Minneapolis, MN; 3Biostatistics, University of Minnesota, Minneapolis, MN.

    OBJECTIVE: Non-skin pretransplant malignancy (NSPTM) has historically been considered a relative contraindication to kidney transplantation (KT). In addition to the conventional risk factors for cancer,…
  • 2018 American Transplant Congress

    HLA-DR4 Matching and Hepatocellular Carcinoma Recurrence after Liver Transplantation

    M. Xu, S. Garcia-Aroz, N. Vachharajani, Y. Lin, W. Chapman.

    Department of Surgery, Section of Abdominal Transplantation, Washington University School of Medicine, St. Louis, MO.

    PURPOSE: The phenomenon of graft versus host disease after orthotopic liver transplantation (OLT) is estimated at approximately 1-2%, suggesting that under some circumstances, the graft…
  • 2018 American Transplant Congress

    Recovery of Wild-Type Genotype after Documented Ganciclovir-Resistance in Transplant Recipients with Recurrent CMV Viremia

    J. Fose, M. Jorgenson, Z. Degrave, R. Redfield, J. Smith, D. Mandelbrot.

    University of Wisconsin Hospital, Madison; University of Wisconsin School of Medicine and Public Health, Madison.

    Purpose: Ganciclovir-resistant cytomegalovirus (GR-CMV) is serious complication after transplantation. Recurrence after primary GR-CMV infection is common, with literature defined rates of approximately 20-30%. It is…
  • 2018 American Transplant Congress

    Preemptive Rituximab in Focal and Segmental Glomerulosclerosis Patients at Risk for Recurrence after Transplantation

    P. Auñon,1 N. Polanco,1 M. Perez,2 E. Rodrigo,3 A. Sancho,4 J. Pascual,2 A. Andres,1 M. Praga.1

    1Nephrology Department, Hospital Doce de Octubre, Madrid, Spain; 2Nephrology Department, Hospital del Mar, Barcelona, Spain; 3Nephrology Department, Hospital Marques de Valdecilla, Santander, Spain; 4Nephrology Department, Hospital Doctor Peset, Valencia, Spain.

    INTRODUCTIONRecurrence of focal and segmental glomerulosclerosis (FSGS) after renal transplantation is a characteristic complication of the disease that occurs in one third of the cases.…
  • 2018 American Transplant Congress

    Durable Donor Hematopoetic Stem Cell (HSC) Chimerism is Associated with Protection from Native Renal Disease Recurrence in Recipients of Combined HSC/Kidney Transplants

    J. Leventhal,1 L. Gallon,1 J. Mathew,1 J. Miller,1 D. Stare,1 S. Ildstad.2

    1Northwestern U, Chicago; 2U Louisville, Louisville.

    Recurrence of the original cause of ESRD has been observed in trials of tolerance induction for kidney transplantation (KTx) where donor HSC have been used…
  • 2018 American Transplant Congress

    Graft Failure in Recurrent IgA Nephropathy Following Living Kidney Transplantation: Predictive Factors Analysis of 102 Biopsies

    J. Zhang, J. Qiu, G. Chen, C. Wang, L. Chen.

    Organ Transplant Unit, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.

    Aim To investigate the predictive factors related to graft failure in recurrentIgA nephropathy (IgAN) following living kidney transplantation. Methods We identified a series of 102…
  • 2018 American Transplant Congress

    FSGS Recurrence and Graft Survival in Pediatric Renal Transplants: A NAPRTCS Registry Analysis

    L. Koh,1 K. Martz,2 T. Blydt-Hansen.3

    1Starship Children's Health, Auckland, New Zealand; 2EMMES Corp., Rockville; 3BC Children's Hospital, Vancouver, Canada.

    IntroductionPrevious studies have raised concern of adverse outcome of living donor (LD) grafts in children transplanted for FSGS. This study reassesses impact of donor source,…
  • 2017 American Transplant Congress

    Predicting Recurrence Prior to Transplant: The Response of HCC to Chemoembolization.

    T. Sandow,1 H. Bohorquez,2 D. Kirsch,1 P. Thevenot,3 K. Nunez,3 A. Albar,1 D. DeVun,1 J. Gimenez,1 G. Galliano,4 A. Cohen,2 G. Loss,2 D. Kay,1 P. Gulotta.1

    1Radiology, Ochsner Clinic Foundation, New Orleans, LA; 2Transplant Surgery, Ochsner Clinic Foundation, New Orleans, LA; 3Institute of Translational Research, Ochsner Clinic Foundation, New Orleans, LA; 4Pathology, Ochsner Clinic Foundation, New Orleans, LA

    Purpose:This study assesses imaging response characteristics of patients with hepatocellular carcinoma (HCC) to chemoembolization (TACE) as a bridge to transplant and the risk of post-transplant…
  • 2017 American Transplant Congress

    Steroid-Free Immunosuppression After Liver Transplant for Autoimmune Disease Does Not Result in Increased Disease Recurrence.

    A. Hooper,1 C. Frenette.2

    1Internal Medicine, Scripps Mercy Hospital, San Diego, CA; 2Organ Transplant, Scripps Green Hospital, La Jolla, CA

    Immunosuppression regimens in patients with end stage liver disease (ESLD) from autoimmune hepatitis (AIH), primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC) typically include…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 15
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences